Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis | Zendy

Adriaan Blommaert | Zendy; Samuel Coenen | Zendy; Birgit Gielen | Zendy; Herman Goossens | Zendy; Niel Hens | Zendy; Philippe Beutels | Zendy

Open Access

Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis

Author(s) -

Adriaan Blommaert,

Samuel Coenen,

Birgit Gielen,

Herman Goossens,

Niel Hens,

Philippe Beutels

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt170

Subject(s) - amoxicillin , medical prescription , antibiotics , medicine , population , pediatrics , reimbursement , antibiotic resistance , intensive care medicine , family medicine , environmental health , health care , pharmacology , biology , microbiology and biotechnology , economics , economic growth

Bacterial resistance to antibiotics, driven by antibiotic consumption, imposes a major threat to the effective treatment of bacterial infections. In addition to reducing the amount of antibiotics prescribed, avoiding broad-spectrum antibiotics could extend the lifetime of the current arsenal of antibiotic substances. Therefore, we documented prescriber and patient characteristics associated with the choice between amoxicillin and broader-spectrum alternatives (co-amoxiclav or moxifloxacin) in recent years in Belgium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research